Achieve greater success in virus detection and removal through access to unpublished data from Europe's leading viral safety experts at the Viral Safety conference taking place in Amsterdam on 25-27 April 2017.
Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in, but don't seem to have lived up to investor expectations
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Join us in San Francisco, CA this April for LEAP HR: Life Sciences West to network with 200+ senior HR leaders
With recent expansion into autoimmune pipelines, the year of the ‘bounce back’ now feels in reach for the NK space.
